New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines

作者: S. Giudice , L. Benassi , G. Bertazzoni , M.P. Costi , A. Gelain

DOI: 10.1016/J.TIV.2006.09.023

关键词:

摘要: Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy. For this reason in the past years a huge variety of new compounds has been developed with potential chemotherapeutic activity which needs be tested vitro vivo. We investigated action three experimental antifolate substances (MR7, MR21 MR36) critical target for thymidylate synthase (TS), an essential enzyme DNA synthesis. The response two cell lines (SK-MEL-2 derived from malignant metastasis SK-MEL-28 primary melanoma) was examined after treatment these substances. agents induced apoptosis SK-MEL-2 cells as confirmed by TUNEL technique Comet Assay. Western-blot analysis showed down-regulation Bcl-2 protein level PARP cleavage, otherwise p53 Bax expressions were not modulated. Moreover, antifolate-induced accompanied both pro-caspase-9 -8 activations. These results supported use pan-caspases inhibitor Z-VAD-FMK that almost completely decreased amount treated antifolate. In conclusion our show TS inhibitors are able induce through caspase-mediated pathway, but without involvement p53/Bax signalling.

参考文章(27)
Maria Paola Costi, Cristina Magnoni, Giorgia Bertazzoni, Tiziana Rossi, Alberto Venturelli, Andrea Coppi, Stefania Giudice, Luisa Benassi, Marcella Rinaldi, Pharmacological and Toxicological Evaluation of a New Series of Thymidylate Synthase Inhibitors as Anticancer Agents Anticancer Research. ,vol. 26, pp. 3499- 3504 ,(2006)
Youcef, M. Rustum, Thymidylate synthase: a critical target in cancer therapy? Frontiers in Bioscience. ,vol. 9, pp. 2467- 2473 ,(2004) , 10.2741/1408
D. W. Nicholson, Life and Death Decisions Science. ,vol. 299, pp. 214- 215 ,(2003) , 10.1126/SCIENCE.1081274
H.H.J Backus, D Wouters, C.G Ferreira, V.M.M van Houten, R.H Brakenhoff, H.M Pinedo, G.J Peters, Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines. European Journal of Cancer. ,vol. 39, pp. 1310- 1317 ,(2003) , 10.1016/S0959-8049(03)00204-1
Jann Lübbe, Martin Reichel, Güner Burg, Paul Kleihues, Absence of p53 Gene Mutations in Cutaneous Melanoma Journal of Investigative Dermatology. ,vol. 102, pp. 819- 821 ,(1994) , 10.1111/1523-1747.EP12381544
Emily H.-Y. Cheng, Beth Levine, Lawrence H. Boise, Craig B. Thompson, J. Marie Hardwick, Bax-independent inhibition of apoptosis by Bcl-XL Nature. ,vol. 379, pp. 554- 556 ,(1996) , 10.1038/379554A0
Anne-Marie Coudray, Christophe Louvet, Michel Kornprobst, Eric Raymond, Thierry André, Christophe Tournigand, Sandrine Faivre, Aimery De Gramont, Annette Larsen, Christian Gespach, Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms. International Journal of Oncology. ,vol. 27, pp. 553- 561 ,(2005) , 10.3892/IJO.27.2.553
A. Ashkenazi, Death Receptors: Signaling and Modulation Science. ,vol. 281, pp. 1305- 1308 ,(1998) , 10.1126/SCIENCE.281.5381.1305